MetLife Investment Management’s Prelude Therapeutics PRLD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,148	Closed	-$130K	–	2541
2021 Q3	$130K	Hold	4,148	–	–	﹤0.01%	2326
2021 Q2	$119K	Hold	4,148	–	–	﹤0.01%	2392
2021 Q1	$180K	Buy	4,148 +29	+0.7%	+$1.26K	﹤0.01%	2111
2020 Q4	$295K	Buy	+4,119	New	+$295K	﹤0.01%	1779